MUCOSAL EOSINOPHILS AS MARKERS OF POST- INDUCTION VEDOLIZUMAB RESPONSE IN PAEDIATRIC ULCERATIVE COLITIS

被引：0
|
作者：
Musto, F. [1 ]
Ranalli, M. [1 ]
Giordano, C. [1 ]
Bianchi, E. [1 ]
Veraldi, S. [1 ]
Oliva, S. [1 ]
D'Arcangelo, G. [1 ]
Aloi, M. [1 ]
机构：
[1] Sapienza Univ, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.14.5
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [41] Predictors of Placebo Induction Response and Remission in Ulcerative Colitis
    Wong, Emily C. L.
    Dulai, Parambir S.
    Marshall, John K.
    Jairath, Vipul
    Reinisch, Walter
    Narula, Neeraj
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1050 - +
  • [42] Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis
    Alipour, Misagh
    Zaidi, Deenaz
    Valcheva, Rosica
    Jovel, Juan
    Martinez, Ines
    Sergi, Consolato
    Walter, Jens
    Mason, Andrew L.
    Wong, Gane Ka-Shu
    Dieleman, Levinus A.
    Carroll, Matthew W.
    Huynh, Hien Q.
    Wine, Eytan
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (04): : 462 - 471
  • [43] Mucosal healing and histological remission in paediatric ulcerative colitis: Does the target change the outcomes?
    D'Arcangelo, G.
    Oliva, S.
    Peresso, M.
    Viola, F.
    Cucchiara, S.
    Aloi, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S211 - S211
  • [44] Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
    Park, S.
    Kang, Y.
    Koh, H.
    Kim, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S407
  • [45] Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
    Kim, Seung
    Park, Sowon
    Kang, Yunkoo
    Koh, Hong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (01) : 17 - 21
  • [46] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [47] Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
    Mosli, Mahmoud H.
    MacDonald, John K.
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    Khanna, Reena
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1151 - 1159
  • [48] Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis
    Church, Peter C.
    Ho, Shaun
    Sharma, Ajay
    Tomalty, Diane
    Frost, Karen
    Muise, Aleixo
    Walters, Thomas D.
    Griffiths, Anne M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 982 - 989
  • [49] Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles
    Fuchs, Friederike
    Schillinger, Daniela
    Atreya, Raja
    Hirschmann, Simon
    Fischer, Sarah
    Neufert, Clemens
    Atreya, Imke
    Neurath, Markus F.
    Zundler, Sebastian
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [50] Response and Remission Rates With up to 3 Years of Vedolizumab Treatment in Patients with Ulcerative Colitis
    Loftus, Edward V.
    Colombel, Jean-Frederic
    Previtali, Alessandro
    Smyth, Michael D.
    GASTROENTEROLOGY, 2016, 150 (04) : S805 - S805
12345